Clinical Scorecard: Amgen Expands Veeva Partnership
At a Glance
| Category | Detail |
|---|---|
| Condition | Commercial technology deployment in the life sciences industry |
| Key Mechanisms | Veeva Vault CRM and AI-enabled tools are intended to support commercial teams, capture evidence from interactions with healthcare professionals, and surface potential treatment-access or uptake barriers. |
| Target Population | Amgen commercial teams; the source also describes interactions with healthcare professionals. |
| Care Setting | Global pharmaceutical and biotechnology commercial operations |
Key Highlights
- Amgen plans to deploy Veeva Vault CRM globally, expanding a collaboration with Veeva Systems that has lasted more than a decade.
- The deployment is intended to provide an AI-enabled commercial technology foundation for Amgen teams.
- Veeva describes the Agentic Call Report as a tool designed to generate “Commercial Evidence” from field interactions and surface potential barriers affecting treatment access or uptake.
- The companies say the capabilities could help improve launch execution and accelerate the delivery of new therapies to patients.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
No patient population or prescribing data are reported.
The article describes a commercial technology deployment, not a treatment or prescribing intervention.
Clinical Best Practices
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
